Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 112
Filter
1.
J Hosp Infect ; 140: 110-116, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37562595

ABSTRACT

OBJECTIVES: Outbreaks of infection related to flexible endoscopes are well described. However, flexible endoscopy also requires the use of ancillary equipment such as irrigation plugs. These are potential vectors of infection but are infrequently highlighted in the literature. This paper reports a cystoscopy-associated outbreak of Pseudomonas aeruginosa from contaminated irrigation plugs in a UK tertiary care centre. METHODS: Laboratory, clinical and decontamination unit records were reviewed, and audits of the decontamination unit were performed. Flexible cystoscopes and irrigation plugs were assessed for contamination. Retrospective and prospective case finding was performed utilizing the microbiology laboratory information management system. Available P. aeruginosa isolates underwent variable nucleotide tandem repeat (VNTR) typing. Confirmed cases were defined as P. aeruginosa infection with an identical VNTR profile to an outbreak strain. RESULTS: Three strains of P. aeruginosa were isolated from five irrigation plugs but none of the flexible cystoscopes. No acquired resistance mechanisms were detected. Fifteen confirmed infections occurred, including bacteraemia, septic arthritis and urinary tract infection. While failure of decontamination likely occurred because the plugs were not dismantled prior to reprocessing, the manufacturer's reprocessing instructions were also incompatible with standard UK practice. The Medicines and Healthcare Products Regulatory Agency was informed. A field safety notice was issued, and the manufacturer issued updated reprocessing instructions. CONCLUSIONS: Ancillary equipment can represent an important vector for infection, and should be considered during outbreak investigations. Users should review the manufacturer's instructions for reprocessing ancillary equipment to ensure that they are compatible with available procedures.


Subject(s)
Cross Infection , Pseudomonas Infections , Humans , Pseudomonas , Cross Infection/epidemiology , Cross Infection/prevention & control , Cross Infection/complications , Retrospective Studies , Disease Outbreaks , Pseudomonas aeruginosa , Pseudomonas Infections/epidemiology , Pseudomonas Infections/prevention & control , Equipment Contamination
2.
Am J Transplant ; 15(6): 1490-501, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25872977

ABSTRACT

Less than 10% of corneal allografts undergo rejection even though HLA matching is not performed. However, second corneal transplants experience a threefold increase in rejection, which is not due to prior sensitization to histocompatibility antigens shared by the first and second transplants since corneal grafts are selected at random without histocompatibility matching. Using a mouse model of penetrating keratoplasty, we found that 50% of the initial corneal transplants survived, yet 100% of the subsequent corneal allografts (unrelated to the first graft) placed in the opposite eye underwent rejection. The severing of corneal nerves that occurs during surgery induced substance P (SP) secretion in both eyes, which disabled T regulatory cells that are required for allograft survival. Administration of an SP antagonist restored immune privilege and promoted graft survival. Thus, corneal surgery produces a sympathetic response that permanently abolishes immune privilege of subsequent corneal allografts, even those placed in the opposite eye and expressing a completely different array of foreign histocompatibility antigens from the first corneal graft.


Subject(s)
Cornea/innervation , Corneal Transplantation , Denervation/methods , Graft Rejection/immunology , Immune Tolerance/immunology , Sensory Receptor Cells , Allografts , Animals , Female , Graft Rejection/physiopathology , Graft Survival/immunology , Graft Survival/physiology , Histocompatibility Antigens/immunology , Immune Tolerance/drug effects , Immune Tolerance/physiology , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred C57BL , Models, Animal , Substance P/antagonists & inhibitors , Substance P/pharmacology , Substance P/physiology , T-Lymphocytes, Regulatory/physiology
3.
Lett Appl Microbiol ; 59(2): 161-8, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24713043

ABSTRACT

UNLABELLED: The effect of the terpenoids gossypol, 6-methoxygossypol, 6,6'-dimethoxygossypol, gossypolone and apogossypolone on growth of fungal soil pathogens was investigated. The compounds were tested at a concentration of 100 µg ml(-1) in a Czapek Dox agar medium at 25°C. Gossypol, gossypolone and apogossypolone demonstrated strong growth inhibitory activity (≥90%) against Pythium irregulare, Pythium ultimum and Fusarium oxysporum. These same terpenoids provided good growth inhibition against most Rhizoctonia solani isolates. Methylated gossypol derivatives generally yielded reduced growth inhibition against the tested fungi compared with gossypol. Dose-response effects of gossypol, gossypolone and apogossypolone were determined over a concentration range of 5-100 µg ml(-1) against P. irregulare CR1, P. ultimum ATCC 56081 and R. solani CR15. At lower concentrations, gossypol proved to be a more potent growth inhibitor of P. irregulare (ED50  = 4 µg ml(-1) ) and P. ultimum (ED50  = 13·2 µg ml(-1) ) than the other tested compounds. Rhizoctonia solani CR15 was more resistant to growth inhibitory effects of all tested terpenoids (ED50  = 35-43 µg ml(-1) ). SIGNIFICANCE AND IMPACT OF THE STUDY: This work demonstrates that gossypol is an effective natural antimicrobial agent against a wide range of potential fungal pathogens of cotton. Relative to gossypol, methylated gossypol derivatives that are also found naturally in root tissue were less effective at inhibiting the growth of soil fungal pathogens. However, by virtue of their significant concentration in root tissue, they still may contribute to cotton defence.


Subject(s)
Gossypium/microbiology , Gossypol/analogs & derivatives , Plant Roots/microbiology , Antifungal Agents/pharmacology , Fusarium/drug effects , Fusarium/growth & development , Gossypol/pharmacology , Inhibitory Concentration 50 , Microbial Sensitivity Tests , Naphthalenes/pharmacology , Phenols/pharmacology , Plant Diseases/microbiology , Pythium/drug effects , Pythium/growth & development , Rhizoctonia/drug effects , Rhizoctonia/growth & development
4.
Prostate Cancer Prostatic Dis ; 17(2): 170-3, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24590360

ABSTRACT

BACKGROUND: To compare prostate cancer detection rates between transrectal ultrasound (TRUS) prostate biopsy and transperineal template prostate biopsy (TPTPB) in biopsy naïve men. TRUS biopsy is still regarded as gold standard for prostate cancer diagnosis. TPTPB has been shown to improve prostate cancer detection in men with rising PSA and previous negative TRUS biopsies. We carried out a prospective study performing both biopsies in the same group of men with a benign feeling digital rectal examination (DRE), PSA <20 ng ml(-1) and no previous prostate biopsies. METHODS: A total of 50 patients with mean age of 67 years (range: 54-84), mean prostate volume 58 cc (range: 19-165) and mean PSA 8 ng l(-1) (range: 4-18) underwent standard 12-core TRUS biopsy followed immediately by 36-core TPTPB under general anaesthetic. We determined the prostate cancer detection rate between the two diagnostic modalities. RESULTS: In total, 20/50 (40%) had benign pathology. Of 30/50 (60%) diagnosed with prostate cancer, 16 (32%) had positive results in both TRUS and TPTPB, whereas 14 (28%) had negative TRUS but positive TPTPB. No cancers were detected solely by TRUS biopsy. TRUS biopsy detected cancer in 32% versus 60% with TPTPB. In total, 19/30(63%) cancers detected by TPTPB had Gleason score > or =7.2 (4%) experienced urosepsis, 7 (14%) temporary urinary retention, 16 (32%) mild haematuria and 19 (38%) haematospermia. CONCLUSIONS: TPTPB is associated with significantly higher prostate cancer detection rate than TRUS biopsies in biopsy naïve men with a benign feeling DRE and PSA <20 ng ml(-1). PSA appears to be better biomarker than previously thought.


Subject(s)
Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/pathology , Aged , Aged, 80 and over , Biopsy/methods , Digital Rectal Examination/methods , Humans , Kallikreins/metabolism , Male , Middle Aged , Prospective Studies , Prostate-Specific Antigen/metabolism , Prostatic Neoplasms/metabolism
5.
Int J Cancer ; 134(5): 1102-11, 2014 Mar 01.
Article in English | MEDLINE | ID: mdl-23959905

ABSTRACT

Bladder cancer patients suffer significant treatment failure, including high rates of recurrence and poor outcomes for advanced disease. If mechanisms to improve tumour cell treatment sensitivity could be identified and/or if tumour response could be predicted, it should be possible to improve local-control and survival. Previously, we have shown that radiation-induced DNA damage, measured by alkaline Comet assay (ACA), correlates bladder cancer cell radiosensitivity in vitro. In this study we first show that modified-ACA measures of cisplatin and mitomycin-C-induced damage also correlate bladder cancer cell chemosensitivity in vitro, with essentially the same rank order for chemosensitivity as for radiosensitivity. Furthermore, ACA studies of radiation-induced damage in different cell-DNA substrates (nuclei, nucleoids and intact parent cells) suggest that it is a feature retained in the prepared nucleoids that is responsible for the relative damage sensitivity of bladder cancer cells, suggestive of differences in the organisation of DNA within resistant vs. sensitive cells. Second, we show that ACA analysis of biopsies from bladder tumours reveal that reduced DNA damage sensitivity associates with poorer treatment outcomes, notably that tumours with a reduced damage response show a significant association with local recurrence of non-invasive disease and that reduced damage response was a better predictor of recurrence than the presence of high-risk histology in this cohort. In conclusion, this study demonstrates that mechanisms governing treatment-induced DNA damage are both central to and predictive of bladder cancer cell treatment sensitivity and exemplifies a link between DNA damage resistance and both treatment response and tumour aggression.


Subject(s)
Comet Assay/methods , DNA Damage , Urinary Bladder Neoplasms/drug therapy , Cell Line, Tumor , Cisplatin/pharmacology , Humans , Mitomycin/pharmacology , Treatment Outcome , Urinary Bladder Neoplasms/genetics
6.
Ann R Coll Surg Engl ; 95(6): e105-6, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24025281

ABSTRACT

Instillagel(®) (CliniMed, High Wycombe, UK) is commonly used in urethral catheterisation and to facilitate the passage of instruments into the bladder in urological practice. Its active ingredients include 0.25% chlorhexidine, 2% lidocaine, 0.06% methyl hydroxybenzoate and 0.025% propyl hydroxybenzoate. We discuss the case of an 84-year-old man who received intraurethral Instillagel(®) prior to laser ablation of a recurrent transitional cell carcinoma of the bladder, resulting in anaphylaxis. Subsequent investigation confirmed allergy to chlorhexidine. Although there are previous reports in the literature, this is the first report of intraurethral chlorhexidine resulting in anaphylaxis in a patient who had had repeated, uneventful previous exposures. As such, this case illustrates the phenomenon of chlorhexidine sensitisation and that previous uneventful exposures do not exclude the diagnosis of anaphylaxis in the context of sudden, unexpected deterioration.


Subject(s)
Anaphylaxis/chemically induced , Anti-Infective Agents, Local/adverse effects , Chlorhexidine/adverse effects , Drug Hypersensitivity/etiology , Lidocaine/adverse effects , Urinary Catheterization/adverse effects , Aged, 80 and over , Anti-Infective Agents, Local/administration & dosage , Chlorhexidine/administration & dosage , Cystoscopy/adverse effects , Drug Combinations , Humans , Lidocaine/administration & dosage , Male
7.
J Appl Microbiol ; 115(1): 179-86, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23594138

ABSTRACT

AIMS: To investigate the effects of temperature and medium composition on growth/aflatoxin inhibitory activities of terpenoids gossypol, gossypolone and apogossypolone against Aspergillus flavus and A. parasiticus. METHODS AND RESULTS: The compounds were tested at a concentration of 100 µg ml(-1) in a Czapek Dox (Czapek) agar medium at 25, 31 and 37°C. Increased incubation temperature marginally increased growth inhibition caused by these compounds, but reduced the aflatoxin inhibition effected by gossypol. Gossypolone and apogossypolone retained good aflatoxin inhibitory activity against A. flavus and A. parasiticus at higher incubation temperatures. However, increased temperature also significantly reduced aflatoxin production in control cultures. The effects of the terpenoids on fungal growth and aflatoxin production against the same fungi were also determined in Czapek, Czapek with a protein/amino acid addendum and yeast extract sucrose (YES) media. Growth of these fungi in the protein-supplemented Czapek medium or in the YES medium greatly reduced the growth inhibition effects of the terpenoids. Apogossypolone displayed strong anti-aflatoxigenic activity in the Czapek medium, but this activity was significantly reduced in the protein-amended Czapek and YES media. Gossypol, which displayed little to no aflatoxin inhibitory activity in the Czapek medium, did yield significant anti-aflatoxigenic activity in the YES medium. CONCLUSIONS: Incubation temperature and media composition are important parameters involved in the regulation of aflatoxin production in A. flavus and A. parasiticus. These parameters also affect the potency of growth and aflatoxin inhibitory activities of these gossypol-related compounds against aflatoxigenic fungi. SIGNIFICANCE AND IMPACT OF THE STUDY: Studies utilizing gossypol-related compounds as inhibitory agents of biological activities should be interpreted with caution due to compound interaction with multiple components of the test system, especially serum proteins.


Subject(s)
Aflatoxins/biosynthesis , Antifungal Agents/pharmacology , Aspergillus flavus/drug effects , Aspergillus/drug effects , Gossypol/pharmacology , Agar , Antifungal Agents/chemistry , Aspergillus/growth & development , Aspergillus/metabolism , Aspergillus flavus/growth & development , Aspergillus flavus/metabolism , Culture Media , Gossypol/analogs & derivatives , Gossypol/chemistry , Temperature
8.
Curr Cancer Drug Targets ; 13(1): 57-68, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22920439

ABSTRACT

Effective treatments to prevent recurrence or progression of non-muscle-invasive bladder cancer, or to inhibit metastasis of muscle-invasive forms of the disease, would deliver significant patient benefit. Here the involvement of STAT signalling and the chemopreventive potential of diindolylmethane (DIM) in human bladder cancer were investigated. Muscle-invasive bladder cancer tissues were characterised by nuclear expression of phosphorylated STAT1, 3 and 5. In E-cadherin positive tumour cell lines (RT112, RT4, HT1376), STAT5 was constitutively phosphorylated, while E-cadherin negative lines (J82, T24, UMUC3) contained phosphoSTAT3. Knockdown of STAT3 induced G0/G1 arrest and inhibited adhesion in J82 cells. Knockdown of STAT1inhibited migration in J82 and RT112 lines. No significant increase in apoptosis was observed. In response to the Janus kinase inhibitor, AG490, RT112 and J82 cells initially underwent G0/G1 arrest, with RT112 cells subsequently exhibiting S phase arrest. Phosphorylation of STAT1(Tyr701), STAT3(Tyr705) and (Ser727) and STAT5(Tyr694) was inhibited by DIM, as was adhesion of J82 cells to collagen, an effect that was enhanced when STAT1 or 3 was reduced by siRNA. However, over-expression of STAT3C partially rescued the DIM inhibitory effect on collagen-mediated adhesion. Migration of both lines was inhibited by DIM, while transfection of constitutively active STAT3C enhanced migration of RT112 cells. DIM induced cell cycle arrest and apoptosis in three cell lines with different degrees of radioresistance. Taken together, these results suggest that inhibition of STAT signalling and/or treatment with DIM may decrease invasiveness of bladder cancer. DIM can induce apoptosis in cell lines which are radioresistant, so in combination with radiotherapy may be useful in overcoming such resistance.


Subject(s)
Antineoplastic Agents/pharmacology , Indoles/pharmacology , Neoplasm Proteins/antagonists & inhibitors , STAT Transcription Factors/antagonists & inhibitors , Signal Transduction/drug effects , Urinary Bladder Neoplasms/drug therapy , Apoptosis/drug effects , Cell Adhesion/drug effects , Cell Cycle/drug effects , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Gene Silencing , Humans , Janus Kinases/antagonists & inhibitors , Molecular Targeted Therapy , Muscle Neoplasms/metabolism , Muscle Neoplasms/pathology , Muscle Neoplasms/secondary , Neoplasm Invasiveness/prevention & control , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Phosphorylation/drug effects , Protein Isoforms/antagonists & inhibitors , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Kinase Inhibitors/pharmacology , Protein Processing, Post-Translational/drug effects , RNA, Small Interfering , STAT Transcription Factors/genetics , STAT Transcription Factors/metabolism , Urinary Bladder/metabolism , Urinary Bladder/pathology , Urinary Bladder Neoplasms/metabolism , Urinary Bladder Neoplasms/pathology
9.
Urol Oncol ; 31(8): 1408-18, 2013 Nov.
Article in English | MEDLINE | ID: mdl-22795499

ABSTRACT

Prostate cancer is the most commonly diagnosed cancer in men. At present, patients are selected for prostate biopsy on the basis of age, serum prostate specific antigen (PSA), and prostatic digital rectal examination (DRE) findings. However, due to limitations in the use of PSA and DRE, many patients undergo unnecessary prostate biopsy. A further problem arises as many patients are diagnosed and treated for indolent disease. This review of the literature highlights the strengths and weaknesses of existing methods of prebiopsy risk stratification and evaluates promising serum, urine, and radiologic prostate cancer biomarkers, which may improve risk stratification for prostate biopsy in the future.


Subject(s)
Digital Rectal Examination , Prostate-Specific Antigen/blood , Prostatic Neoplasms/blood , Prostatic Neoplasms/diagnosis , Biopsy , Humans , Male , Prostate/pathology , Prostatic Neoplasms/pathology , Sensitivity and Specificity
10.
Oncogene ; 31(12): 1493-503, 2012 Mar 22.
Article in English | MEDLINE | ID: mdl-21822309

ABSTRACT

Fos-related antigen 1 (Fra-1) is a Fos family member overexpressed in several types of human cancers. Here, we report that Fra-1 is highly expressed in the muscle-invasive form of the carcinoma of the bladder (80%) and to a lesser extent in superficial bladder cancer (42%). We demonstrate that in this type of cancer Fra-1 is regulated via a C-terminal instability signal and C-terminal phosphorylation. We show that manipulation of Fra-1 expression levels in bladder cancer cell lines affects cell morphology, motility and proliferation. The gene coding for AXL tyrosine kinase is directly upregulated by Fra-1 in bladder cancer and in other cell lines. Importantly, our data demonstrate that AXL mediates the effect of Fra-1 on tumour cell motility but not on cell proliferation. We suggest that AXL may represent an attractive therapeutic target in cancers expressing high Fra-1 levels.


Subject(s)
Cell Movement/genetics , Proto-Oncogene Proteins c-fos/metabolism , Proto-Oncogene Proteins/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Urinary Bladder Neoplasms/genetics , Cell Line, Tumor , Cell Proliferation , Cell Shape/drug effects , Gene Expression Regulation, Neoplastic , Humans , Phosphorylation , Transcriptional Activation , Up-Regulation , Axl Receptor Tyrosine Kinase
11.
Lett Appl Microbiol ; 52(4): 406-12, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21291481

ABSTRACT

AIMS: The objective of this study was to test a series of gossypol-related compounds for growth inhibition against Aspergillus flavus. METHODS AND RESULTS: A series of chiral and achiral gossypol derivatives, some natural products of the cotton plant and others prepared by synthesis from gossypol, were incorporated into agar plates to follow the rate of A. flavus isolate AF13 colony growth. All tested compounds exhibited some growth inhibition against this organism. The synthetic compounds, gossypolone and apogossypolone, exhibited greater activity than either racemic or chiral gossypol. Methylated derivatives (i.e. 6-methoxy and 6,6'-dimethoxy derivatives) generally exhibited less activity than the nonmethylated parent compounds. The (-)-optical form of gossypol was found to be slightly more active than the (+)-optical form, and this trend was observed regardless of the presence of methoxy groups at the 6-position. Growth inhibition of gossypolone and apogossypolone was concentration dependent. For gossypolone, the 50% effective dose was 90 µg ml⁻¹ of medium (165 µmol l⁻¹). For apogossypolone, the most active compound in the study, the 50% effective dose was 19 µg ml⁻¹ (38·7 µmol l⁻¹). The presence of gossypol-related terpenoids appeared to stimulate production of A. flavus sclerotia, although replicate variability was so large that it was not possible to determine a significant correlation between the mass of sclerotia formed and compound growth inhibition. CONCLUSIONS: The quinone derivatives of gossypol, gossypolone and apogossypolone demonstrated significant fungal growth inhibitory activity against A. flavus. SIGNIFICANCE AND IMPACT OF THE STUDY: These gossypol derivatives may provide a new class of fungicide for use against the mycotoxigenic fungus A. flavus.


Subject(s)
Antifungal Agents/pharmacology , Aspergillus flavus/drug effects , Gossypol/analogs & derivatives , Antifungal Agents/chemistry , Aspergillus flavus/growth & development , Gossypol/chemistry , Gossypol/pharmacology
12.
Urol Int ; 85(3): 249-56, 2010.
Article in English | MEDLINE | ID: mdl-20332611

ABSTRACT

INTRODUCTION: The standard treatment for upper urinary tract transitional cell carcinoma (UUT-TCC) is open radical nephroureterectomy with excision of a bladder cuff. We assess the successful endoscopic completion and oncological efficacy of the various minimally invasive transurethral techniques devised for the management of the intramural ureter during nephroureterectomy. MATERIALS AND METHODS: A comprehensive review of the English literature until February 2009 using the PubMed database returned 42 relevant papers. Five methods of endoscopic management of the distal ureter were identified and compared to the open technique. RESULTS: There are no randomised studies. Successful completion of the endoscopic procedure was less (91%) for the ureteric stripping technique than for the other endoscopic modalities (99.8-100%). Recurrences were highest for laparoscopic extravesical ureteric stapling in conjunction with cystoscopic detachment of the ureter, although the numbers analysed were small. For the other endoscopic modalities, bladder recurrence, positive margins and retroperitoneal recurrence (20-37, 0-4 and 1-3%, respectively) in case series were similar compared with the open method (36, 5 and 3%, respectively). CONCLUSIONS: Current non-randomised evidence is open to selection bias and is insufficient to support or refute endoscopic management of the distal ureter as an alternative to open bladder cuff excision. We highlight the reported inefficiency of the ureteric stripping technique.


Subject(s)
Carcinoma, Transitional Cell/surgery , Nephrectomy/methods , Ureter/surgery , Ureteral Neoplasms/surgery , Urologic Surgical Procedures/methods , Endoscopy/methods , Humans , Laparoscopy/methods , Medical Oncology/methods , Nephrology/methods , Recurrence , Treatment Outcome , Urinary Bladder/surgery
13.
Proc Natl Acad Sci U S A ; 106(35): 14884-9, 2009 Sep 01.
Article in English | MEDLINE | ID: mdl-19706487

ABSTRACT

The epithelial-mesenchymal transition (EMT) contributes to cancer metastasis. Two ZEB family members, ZEB1 and ZEB2(SIP1), inhibit transcription of the E-cadherin gene and induce EMT in vitro. However, their relevance to human cancer is insufficiently studied. Here, we performed a comparative study of SIP1 and ZEB1 proteins in cancer cell lines and in one form of human malignancy, carcinoma of the bladder. Whereas ZEB1 protein was expressed in all E-cadherin-negative carcinoma cell lines, being in part responsible for the high motility of bladder cancer cells, SIP1 was hardly ever detectable in carcinoma cells in culture. However, SIP1 represented an independent factor of poor prognosis (P = 0.005) in a series of bladder cancer specimens obtained from patients treated with radiotherapy. In contrast, ZEB1 was rarely expressed in tumor tissues; and E-cadherin status did not correlate with the patients' survival. SIP1 protected cells from UV- and cisplatin-induced apoptosis in vitro but had no effect on the level of DNA damage. The anti-apoptotic effect of SIP1 was independent of either cell cycle arrest or loss of cell-cell adhesion and was associated with reduced phosphorylation of ATM/ATR targets in UV-treated cells. The prognostic value of SIP1 and its role in DNA damage response establish a link between genetic instability and metastasis and suggest a potential importance for this protein as a therapeutic target. In addition, we conclude that the nature of an EMT pathway rather than the deregulation of E-cadherin per se is critical for the progression of the disease and patients' survival.


Subject(s)
Apoptosis , DNA Damage , Homeodomain Proteins/metabolism , Repressor Proteins/metabolism , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/metabolism , Cadherins/metabolism , Cell Line, Tumor , Gene Expression Regulation, Neoplastic , Homeodomain Proteins/genetics , Humans , Neoplasm Invasiveness , Phenotype , Prognosis , Repressor Proteins/genetics , Survival Rate , Transcription Factors/metabolism , Treatment Outcome , Urinary Bladder Neoplasms/pathology , Urinary Bladder Neoplasms/radiotherapy , Zinc Finger E-box Binding Homeobox 2 , Zinc Finger E-box-Binding Homeobox 1
14.
Ann R Coll Surg Engl ; 91(6): 532-4, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19558768

ABSTRACT

Three cases of recurrent post-coital haematuria are described. Extensive protracted investigations pinpointed urethral varicosities as the likely cause. All patients were successfully treated with diathermy fulguration.


Subject(s)
Coitus , Hematuria/etiology , Hemospermia/etiology , Urethra/blood supply , Varicose Veins/complications , Adult , Ejaculation , Electrocoagulation , Hematuria/surgery , Hemospermia/surgery , Humans , Male , Middle Aged , Recurrence , Treatment Outcome
15.
Am J Transplant ; 9(5): 1017-26, 2009 May.
Article in English | MEDLINE | ID: mdl-19422331

ABSTRACT

Corneal allografts transplanted into hosts with allergic conjunctivitis experience an increased incidence and swifter tempo of immune rejection compared to corneal allografts transplanted to nonallergic hosts. Previous findings suggested that increased risk for rejection was not a local effect produced by an inflamed eye, but was due to perturbation of the systemic immune responses to alloantigens on the corneal allograft. We tested the hypothesis that another allergic disease, airway hyperreactivity (AHR), would also increase the risk for corneal allograft rejection. Induction of AHR with either ovalbumin (OVA) or short ragweed (SRW) extract prior to keratoplasty resulted in a steep increase in the speed and incidence of corneal allograft rejection. Delayed-type hypersensitivity (DTH) responses to corneal alloantigens were closely associated with corneal allograft rejection. However, the deleterious effect of AHR on corneal allograft survival was not reflected in a heightened magnitude of allospecific DTH, cytotoxic T lymphocyte and lymphoproliferative responses to the alloantigens on the corneal allograft. Unlike Th2-based immediate hypersensitivity, CD8+ T-cell-based contact hypersensitivity to oxazolone did not increase the risk for corneal allograft rejection. Thus, Th2-based allergic diseases significantly reduce the immune privilege of the corneal allograft and represent important risk factors for consideration in the atopic patient.


Subject(s)
Bronchial Hyperreactivity/complications , Conjunctivitis, Allergic/surgery , Corneal Transplantation , Graft Rejection/epidemiology , T-Lymphocytes, Cytotoxic/immunology , Animals , Asthma/immunology , Bronchial Hyperreactivity/immunology , CD8-Positive T-Lymphocytes/immunology , Disease Models, Animal , Female , Graft Survival/immunology , Isoantigens/analysis , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Ovalbumin/immunology , Ovalbumin/therapeutic use , Risk Factors , Transplantation, Homologous/immunology
16.
Int J Oncol ; 34(4): 1155-63, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19287975

ABSTRACT

Survival rate of patients diagnosed with the invasive form of bladder cancer is low suggesting an urgent need to implement novel treatments. GTC (gemcitabine, paclitaxel and cisplatin) is a new chemotherapeutic regimen, which has shown promise in clinical trials. Given that receptor tyrosine kinases of the ErbB family are overexpressed in a high proportion of metastatic bladder tumours, approaches involving small-molecule inhibitors of ErbB receptors in combination with conventional cytostatic drugs are of potential interest. Here, we show that the dual inhibitor of ErbB receptors, lapatinib, enhances cytostatic and induces cytotoxic effects of GTC in two bladder cancer cell lines which differ with regard to expression levels of proteins taking part in the ErbB pathway. Lapatinib inhibited phosphorylation of ErbB receptors and also reduced the level of phosphorylated AKT. Flow cytometry analysis demonstrated that GTC treatment affects cell cycle distribution differently in the presence or absence of lapatinib. In RT112 cells, which express high levels of ErbB receptors and harbour wild-type p53, combined GTC/lapatinib treatment resulted in the phosphorylation of p53 at Ser46 and accumulation of sub-G1 cell populations. Our data indicate that a combinatorial approach involving GTC and lapatinib may have therapeutic potential in a subset of bladder tumours depending on the genetic context.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , ErbB Receptors/antagonists & inhibitors , Quinazolines/pharmacology , Receptor, ErbB-2/antagonists & inhibitors , Urinary Bladder Neoplasms/drug therapy , Cell Line, Tumor , Cell Separation , Epidermal Growth Factor/metabolism , Flow Cytometry , Humans , Inhibitory Concentration 50 , Lapatinib , Phosphorylation , Signal Transduction , Treatment Outcome
17.
Rapid Commun Mass Spectrom ; 23(2): 258-66, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19072863

ABSTRACT

Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) represents a non-invasive biomarker for oxidative stress and may be useful for monitoring chemotherapeutic and chemopreventive interventions associated with cancer-related alterations in oxidative stress. We describe the development and validation of two separate liquid chromatography/tandem mass spectrometry (LC/MS/MS) selected reaction monitoring (SRM) methods for the determination of 8-oxodG and creatinine in both murine and human urine using stable isotope labelled internal standards. Levels of 8-oxodG were normalised to creatinine. The LC/MS/MS methods were applied to two chemoprevention studies utilising tea polyphenols in humans and TRAMP (TRansgenic Adenocarcinoma of the Mouse Prostate) mice. Patients with benign prostatic hyperplasia received 1 g/day of green tea polyphenols (GTP), 1 g/day of black tea theaflavins (BTT) or no treatment for 4 weeks. TRAMP mice received GTP (0.05% in drinking water) for 4 or 25 weeks. Prostate pathology in TRAMP mice was not affected by GTP. Levels of 8-oxodG were not altered by tea polyphenols in either mice or humans. In TRAMP mice, urinary 8-oxodG levels were elevated with increasing age (p < 0.0001) but not changed by the presence of prostate tumours. In conclusion, the LC/MS/MS SRM methods described here are ideally suited for the accurate determination of 8-oxodG and creatinine in urine samples from both clinical and pre-clinical studies.


Subject(s)
Chromatography, High Pressure Liquid/methods , Creatinine/urine , Deoxyguanosine/analogs & derivatives , Plant Extracts/pharmacokinetics , Prostatic Neoplasms/urine , Spectrometry, Mass, Electrospray Ionization/methods , Tea/chemistry , Urinalysis/methods , 8-Hydroxy-2'-Deoxyguanosine , Adenocarcinoma/urine , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacokinetics , Cell Line, Tumor , Deoxyguanosine/urine , Humans , Male , Mice , Mice, Inbred C57BL , Plant Extracts/administration & dosage , Reproducibility of Results , Sensitivity and Specificity
18.
Cancer Lett ; 261(1): 74-83, 2008 Mar 08.
Article in English | MEDLINE | ID: mdl-18096312

ABSTRACT

Intracellular reactive oxygen species (ROS) may cause oxidative DNA damage, resulting in the formation of adducts such as 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG) and the cyclic pyrimidopurinone N-1, N(2) malondialdehyde-2'-deoxyguanosine (M(1)dG). These adducts have been associated with carcinogenesis, genomic instability and clonal evolution. We tested two hypotheses in human prostate cancer cells grown in vitro and in a xenograft model: (1) treatment of androgen-sensitive cells with DHT increases levels of oxidative DNA adduct levels; (2) flutamide, a competitive androgen receptor antagonist, prevents DHT-induced changes. Levels of M(1)dG and 8-oxo-dG adducts were determined by immunoslot blot and liquid chromatography-tandem mass spectrometry. M(1)dG and 8-oxo-dG levels were significantly higher than control levels in LNCaP cells exposed to supra-physiological concentrations (25-100 nM) of DHT (both P<0.05 by ANOVA). Flutamide pre-treatment completely prevented this increase. In the xenograft model, tumour levels of M(1)dG were decreased by 46% (P=0.001 by Mann-Whitney Test) in flutamide-treated animals compared to controls. The changes demonstrated suggest that oxidative DNA adducts may serve as biomarkers of the efficacy of androgen manipulation in chemoprevention trials.


Subject(s)
Androgens/pharmacology , DNA Adducts/metabolism , Neoplasms, Hormone-Dependent/metabolism , Prostatic Neoplasms/metabolism , Reactive Oxygen Species/metabolism , Animals , Cell Line, Tumor , DNA Damage , Dihydrotestosterone/pharmacology , Flutamide/pharmacology , Humans , Male , Mice , Neoplasm Transplantation
19.
Mol Biol Cell ; 18(11): 4615-24, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17855508

ABSTRACT

Zinc finger transcription factors of the Snail/Slug and ZEB-1/SIP1 families control epithelial-mesenchymal transitions in development in cancer. Here, we studied SIP1-regulated mesenchymal conversion of epidermoid A431 cells. We found that concomitant with inducing invasive phenotype, SIP1 inhibited expression of cyclin D1 and induced hypophosphorylation of the Rb tumor suppressor protein. Repression of cyclin D1 was caused by direct binding of SIP1 to three sequence elements in the cyclin D1 gene promoter. By expressing exogenous cyclin D1 in A431/SIP1 cells and using RNA interference, we demonstrated that the repression of cyclin D1 gene by SIP1 was necessary and sufficient for Rb hypophosphorylation and accumulation of cells in G1 phase. A431 cells expressing SIP1 along with exogenous cyclin D1 were highly invasive, indicating that SIP1-regulated invasion is independent of attenuation of G1/S progression. However, in another epithelial-mesenchymal transition model, gradual mesenchymal conversion of A431 cells induced by a dominant negative mutant of E-cadherin produced no effect on the cell cycle. We suggest that impaired G1/S phase progression is a general feature of cells that have undergone EMT induced by transcription factors of the Snail/Slug and ZEB-1/SIP1 families.


Subject(s)
Cell Cycle , Cyclin D1/metabolism , Epithelial Cells/cytology , Epithelial Cells/metabolism , Mesoderm/cytology , Mesoderm/metabolism , Nerve Tissue Proteins/metabolism , RNA-Binding Proteins/metabolism , Cadherins/genetics , Cadherins/metabolism , Cell Line, Tumor , Cyclin D1/genetics , Down-Regulation , Humans , Mutation/genetics , Nerve Tissue Proteins/genetics , Promoter Regions, Genetic/genetics , RNA-Binding Proteins/genetics , Transcription, Genetic/genetics
20.
Clin Oncol (R Coll Radiol) ; 19(10): 777-83, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17706406

ABSTRACT

AIMS: Carbonic anhydrase IX (CA IX) expression has been described as an endogenous marker of hypoxia in solid neoplasms. Furthermore, CA IX expression has been associated with an aggressive phenotype and resistance to radiotherapy. We assessed the prognostic significance of CA IX expression in patients with muscle-invasive bladder cancer treated with radiotherapy. MATERIALS AND METHODS: A standard immunohistochemistry technique was used to show CA IX expression in 110 muscle-invasive bladder tumours treated with radiotherapy. Clinicopathological data were obtained from medical case notes. RESULTS: CA IX immunostaining was detected in 89 ( approximately 81%) patients. Staining was predominantly membranous, with areas of concurrent cytoplasmic and nuclear staining and was abundant in luminal and perinecrotic areas. No significant correlation was shown between the overall CA IX status and the initial response to radiotherapy, 5-year bladder cancer-specific survival or the time to local recurrence. CONCLUSIONS: The distribution of CA IX expression in paraffin-embedded tissue sections seen in this series is consistent with previous studies in bladder cancer, but does not provide significant prognostic information with respect to the response to radiotherapy at 3 months and disease-specific survival after radical radiotherapy.


Subject(s)
Antigens, Neoplasm/metabolism , Carbonic Anhydrases/metabolism , Neoplasm Recurrence, Local , Urinary Bladder Neoplasms/metabolism , Urinary Bladder Neoplasms/radiotherapy , Aged , Aged, 80 and over , Carbonic Anhydrase IX , Disease-Free Survival , Female , Gene Expression Profiling , Humans , Male , Middle Aged , Prognosis , Urinary Bladder Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...